BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 26114584)

  • 1. Disruption of thioredoxin metabolism enhances the toxicity of transforming growth factor β-activated kinase 1 (TAK1) inhibition in KRAS-mutated colon cancer cells.
    Hrabe JE; O'Leary BR; Fath MA; Rodman SN; Button AM; Domann FE; Spitz DR; Mezhir JJ
    Redox Biol; 2015 Aug; 5():319-327. PubMed ID: 26114584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism and in vitro pharmacology of TAK1 inhibition by (5Z)-7-Oxozeaenol.
    Wu J; Powell F; Larsen NA; Lai Z; Byth KF; Read J; Gu RF; Roth M; Toader D; Saeh JC; Chen H
    ACS Chem Biol; 2013 Mar; 8(3):643-50. PubMed ID: 23272696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of hyperthermia-induced apoptosis by 5Z-7-oxozeaenol, a TAK1 inhibitor, in A549 cells.
    Li P; Zhao QL; Jawaid P; Rehman MU; Sakurai H; Kondo T
    Cell Stress Chaperones; 2016 Sep; 21(5):873-81. PubMed ID: 27448221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous inhibition of glutathione- and thioredoxin-dependent metabolism is necessary to potentiate 17AAG-induced cancer cell killing via oxidative stress.
    Scarbrough PM; Mapuskar KA; Mattson DM; Gius D; Watson WH; Spitz DR
    Free Radic Biol Med; 2012 Jan; 52(2):436-43. PubMed ID: 22100505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic action of 5Z-7-oxozeaenol and bortezomib in inducing apoptosis of Burkitt lymphoma cell line Daudi.
    Zhang J; Li B; Wu H; Ou J; Wei R; Liu J; Cai W; Liu X; Zhao S; Yang J; Zhou L; Liu S; Liang A
    Tumour Biol; 2016 Jan; 37(1):531-9. PubMed ID: 26227222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A resorcylic acid lactone, 5Z-7-oxozeaenol, prevents inflammation by inhibiting the catalytic activity of TAK1 MAPK kinase kinase.
    Ninomiya-Tsuji J; Kajino T; Ono K; Ohtomo T; Matsumoto M; Shiina M; Mihara M; Tsuchiya M; Matsumoto K
    J Biol Chem; 2003 May; 278(20):18485-90. PubMed ID: 12624112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of Radiation Response in Breast Cancer Stem Cells by Inhibition of Thioredoxin- and Glutathione-Dependent Metabolism.
    Rodman SN; Spence JM; Ronnfeldt TJ; Zhu Y; Solst SR; O'Neill RA; Allen BG; Guan X; Spitz DR; Fath MA
    Radiat Res; 2016 Oct; 186(4):385-395. PubMed ID: 27643875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical application of TAK1 inhibitor encapsulated by gelatin particle alleviates corneal neovascularization.
    Wang JH; Tseng CL; Lin FL; Chen J; Hsieh EH; Lama S; Chuang YF; Kumar S; Zhu L; McGuinness MB; Hernandez J; Tu L; Wang PY; Liu GS
    Theranostics; 2022; 12(2):657-674. PubMed ID: 34976206
    [No Abstract]   [Full Text] [Related]  

  • 9. TAK1 inhibitor 5Z-7-oxozeaenol sensitizes cervical cancer to doxorubicin-induced apoptosis.
    Guan S; Lu J; Zhao Y; Woodfield SE; Zhang H; Xu X; Yu Y; Zhao J; Bieerkehazhi S; Liang H; Yang J; Zhang F; Sun S
    Oncotarget; 2017 May; 8(20):33666-33675. PubMed ID: 28430599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor β-activated kinase 1 inhibitor suppresses the proliferation in triple-negative breast cancer through TGF-β/TGFR pathway.
    Zhang L; Fu Z; Li X; Tang H; Luo J; Zhang D; Zhuang Y; Han Z; Yin M
    Chem Biol Drug Des; 2017 Sep; 90(3):450-455. PubMed ID: 28224764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TAK1 inhibitor 5Z-7-oxozeaenol sensitizes neuroblastoma to chemotherapy.
    Fan Y; Cheng J; Vasudevan SA; Patel RH; Liang L; Xu X; Zhao Y; Jia W; Lu F; Zhang H; Nuchtern JG; Kim ES; Yang J
    Apoptosis; 2013 Oct; 18(10):1224-34. PubMed ID: 23700229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility of human head and neck cancer cells to combined inhibition of glutathione and thioredoxin metabolism.
    Sobhakumari A; Love-Homan L; Fletcher EV; Martin SM; Parsons AD; Spitz DR; Knudson CM; Simons AL
    PLoS One; 2012; 7(10):e48175. PubMed ID: 23118946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation, semisynthesis, covalent docking and transforming growth factor beta-activated kinase 1 (TAK1)-inhibitory activities of (5Z)-7-oxozeaenol analogues.
    Fakhouri L; El-Elimat T; Hurst DP; Reggio PH; Pearce CJ; Oberlies NH; Croatt MP
    Bioorg Med Chem; 2015 Nov; 23(21):6993-9. PubMed ID: 26481152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of carboplatin-mediated lung cancer cell killing by simultaneous disruption of glutathione and thioredoxin metabolism.
    Fath MA; Ahmad IM; Smith CJ; Spence J; Spitz DR
    Clin Cancer Res; 2011 Oct; 17(19):6206-17. PubMed ID: 21844013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGFβ1-induced SMAD2/3 and SMAD1/5 phosphorylation are both ALK5-kinase-dependent in primary chondrocytes and mediated by TAK1 kinase activity.
    van Caam A; Madej W; Garcia de Vinuesa A; Goumans MJ; Ten Dijke P; Blaney Davidson E; van der Kraan P
    Arthritis Res Ther; 2017 May; 19(1):112. PubMed ID: 28569204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual pharmacological inhibition of glutathione and thioredoxin systems synergizes to kill colorectal carcinoma stem cells.
    Tanaka G; Inoue K; Shimizu T; Akimoto K; Kubota K
    Cancer Med; 2016 Sep; 5(9):2544-57. PubMed ID: 27485632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGFβ-activated Kinase 1 (TAK1) Inhibition by 5Z-7-Oxozeaenol Attenuates Early Brain Injury after Experimental Subarachnoid Hemorrhage.
    Zhang D; Yan H; Li H; Hao S; Zhuang Z; Liu M; Sun Q; Yang Y; Zhou M; Li K; Hang C
    J Biol Chem; 2015 Aug; 290(32):19900-9. PubMed ID: 26100626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivation of transforming growth factor-β-activated kinase 1 promotes taxol efficacy in ovarian cancer cells.
    Bo L; Cui H; Fang Z; Qun T; Xia C
    Biomed Pharmacother; 2016 Dec; 84():917-924. PubMed ID: 27764753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined inhibition of glycolysis, the pentose cycle, and thioredoxin metabolism selectively increases cytotoxicity and oxidative stress in human breast and prostate cancer.
    Li L; Fath MA; Scarbrough PM; Watson WH; Spitz DR
    Redox Biol; 2015; 4():127-35. PubMed ID: 25560241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting redox homeostasis in rhabdomyosarcoma cells: GSH-depleting agents enhance auranofin-induced cell death.
    Habermann KJ; Grünewald L; van Wijk S; Fulda S
    Cell Death Dis; 2017 Oct; 8(10):e3067. PubMed ID: 28981107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.